Back

INVICTUS - Rivaroxaban versus VKA for rheumatic atrial fibrillation.

28 August 2022 (08:30 - 08:42)
Organised by:
Congress Presentation Part of: HOT LINE SESSION 5 Oral Anticoagulation ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Professor Ganesan Karthikeyan

All India Institute of Medical Sciences AIIMS New Delhi, New Delhi (India)

11 More presentations in this session

Presentation thumbnail
Discussant review - INVICTUS.
Professor R. Lopes (Durham, US)
Slides Video
Presentation thumbnail
Panel discussion - INVICTUS.
Video
Presentation thumbnail
PACIFIC-AMI - Efficacy and safety of factor XIa inhibitor asundexian on top of dual antiplatelet therapy after acute myocardial infarction .
Professor J. Alexander (Durham, US)
Slides Video
Presentation thumbnail
Discussant review - PACIFIC-AMI.
Doctor M. O'Donoghue (Boston, US)
Slides Video
Presentation thumbnail
Panel discussion - PACIFIC-AMI.
Video

Access the full session

Session thumbnail
HOT LINE SESSION 5
Video

The Event

Event poster

ESC Congress 2022

28 August 2022 08:30 CET
You may be interested in
thumbnail
Congress Session
Daily Highlights Programme - Argentine Society of Cardiology 2
28 August 2022
thumbnail
Congress Presentation
INVICTUS program: Mortality in rheumatic heart disease
25 August 2023
thumbnail
Congress Presentation
What is coming now?
31 August 2025
thumbnail
Congress Presentation
RIVER: Rivaroxaban for Valvular Heart Disease and Atrial Fibrillation
28 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources